← Back to Search

ED Tracking Sheet Implementation

N/A
Waitlist Available
Led By Harman Gill, MD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time of ed presentation to the time of in-hospital death or hospital discharge, approximately 2 weeks
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to assess whether implementation of an ED Sepsis Tracking Sheet effects the percentage of goal-directed sepsis criteria met in a tertiary care academic Emergency Department.

Eligible Conditions
  • Sepsis
  • Systemic Inflammatory Response Syndrome
  • Staphylococcal Sepsis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time of ed presentation to the time of in-hospital death or hospital discharge, approximately 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and time of ed presentation to the time of in-hospital death or hospital discharge, approximately 2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Septicemia
Secondary study objectives
In-hospital mortality
Length of hospital stay

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Post-interventionExperimental Treatment1 Intervention
Patients presenting to the Emergency Department meeting severe sepsis criteria following implementation of an ED Sepsis Tracking Sheet
Group II: Pre-interventionActive Control1 Intervention
Patients presenting to the Emergency Department meeting severe sepsis criteria prior to implementation of an ED Sepsis Tracking Sheet
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ED Sepsis Tracking Sheet
2021
N/A
~200

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
538 Previous Clinical Trials
2,539,537 Total Patients Enrolled
Harman Gill, MDPrincipal InvestigatorDartmouth-Hitchcock Medical Center
~44 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top